H. Lundbeck A/s

This study tests a medicine called Lu AG22515 in 20 adults with moderate-to-severe thyroid eye disease, an autoimmune condition that causes eye swelling and bulging. The main goal is to see if the treatment reduces bulging eyes over 24 weeks. Researchers will also check how the d…

This study tests an experimental drug called Lu AF82422 in 64 people with multiple system atrophy (MSA), a rare and serious brain disease. The goal is to see if the drug can slow down the worsening of symptoms like movement problems and daily living difficulties. Participants rec…

This phase 3 trial tests a drug called amlenetug in 401 people with multiple system atrophy (MSA), a rare and serious brain disorder. The goal is to see if the drug can slow the disease's progression and help people live longer. Participants receive either the drug or a placebo, …

This study tests a new drug called Lu AG09222 to see if it can prevent migraines in people who have already tried 1 to 4 other preventive medications without success. About 874 adults with frequent migraines (at least 4 per month) will receive either the drug or a placebo to find…

This study tests whether eptinezumab can reduce migraine days and improve quality of life in 150 adults who have migraines at least 8 days per month and did not get enough relief from previous CGRP-targeting therapies. Participants receive the drug and report changes in symptoms …

This study follows 90 people with Multiple System Atrophy (MSA) in China and Europe for 12 months to understand how the disease progresses. Researchers will use regular check-ups, brain scans, and blood tests to measure changes. The goal is to gather information that could help d…